OCT 26, 2020 9:00 AM PDT

Attacking leukemia trojan horse style

Researchers from the Max Planck Institute of Biochemistry have developed a new approach to targeting leukemic stem cells, the cells that grow into leukemia. The approach is published in the Proceedings of the National Academy of Sciences and works by removing leukemic stem cells from where they reside in the bone marrow.

Leukemic stem cells are found in very specific environments in the bone marrow called malignant niches. It is within a malignant niche that leukemic stem cells can survive and multiply. So, in order to stay physically attached to the niche, these cells use integrins to bind themselves to the extracellular matrix, a process that is only possible with the help of an intracellular protein called Kindlin-3.

So, thought the research team, if there is no Kindlin-3, can there be no leukemia? In investigating this question, the researchers used mice models to test out their idea: deliver a Kindlin-3 destroying siRNA compound into leukemic stem cells in order to disable leukemic stem cells’ survival tool.

The first author of the study, Peter Krenn, explains: "The isoform Kindlin-3 is only used by blood cells. If mice harbor leukemic stem cells that lack Kindlin-3, they do not develop leukemia. Without Kindlin-3 and active integrins, the leukemic stem cells cannot attach themselves to their niche environment and are released from the bone marrow into the blood. Since they cannot home elsewhere either, they remain in the blood. There the leukemic stem cells lack the urgently needed support, which they usually receive from the niche, and die."

 A stem cell transplant can help restore healthy bone marrow in patients with leukemia. Photo: Pixabay

Krenn continues: "In our current study we have developed a new therapeutic approach to treat chronic myeloid leukemia in mice. However, the principle of the therapy is universally valid. The inhibited Kindlin-3 production and consequent loss of integrin function prevents the cancer cells from being able to adhere and settle in tumor-promoting niches. I assume that this method will also prevent the cancer cells of other types of leukemia from settling and that these diseases could thus become much more treatable."

The researchers look forward to continuing their investigations in order to explore further strategies to fight leukemia.

Sources: PNAS, Science Daily

About the Author
BA Environmental Studies
Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
AUG 18, 2022
Cancer
Why are Men More Prone to Cancer than Women?
AUG 18, 2022
Why are Men More Prone to Cancer than Women?
The overall risk of developing cancer is about the same for men and women (40.2% and 38.5%, respectively).  However ...
SEP 01, 2022
Cancer
Pre-clinical Study Describes a Strategy to Improve Adoptive Cell Therapy
SEP 01, 2022
Pre-clinical Study Describes a Strategy to Improve Adoptive Cell Therapy
Immune cells, known as T cells (also called T lymphocytes), play a vital role in the anti-tumor immune response.  T ...
SEP 04, 2022
Drug Discovery & Development
Brief Exposure to Cancer Drug Produces Anti-aging Effects in Mice
SEP 04, 2022
Brief Exposure to Cancer Drug Produces Anti-aging Effects in Mice
Brief exposure to rapamycin, a promising anti-aging drug, may have similar effects on health and lifespan as longer trea ...
SEP 28, 2022
Drug Discovery & Development
Impact of In Vivo Controls on Therapeutic Drug Development
SEP 28, 2022
Impact of In Vivo Controls on Therapeutic Drug Development
The significance of antibody based in vivo studies   For both research and therapeutic purposes, antibodies ca ...
NOV 03, 2022
Cancer
Uterine Cancer Linked to Hair Straightening Products
NOV 03, 2022
Uterine Cancer Linked to Hair Straightening Products
While uterine cancer represents only 3% of all cancer diagnoses in the United States, it remains the most common female ...
NOV 29, 2022
Drug Discovery & Development
Chemotherapy May Increase Disease Susceptibility for Two Generations
NOV 29, 2022
Chemotherapy May Increase Disease Susceptibility for Two Generations
A common chemotherapy drug may make future generations more susceptible to disease. The corresponding study was publishe ...
Loading Comments...